Stockholder Equity - Schedule of Warrants (Details) - Warrants [Member] - $ / shares |
3 Months Ended | |||
|---|---|---|---|---|
Jan. 01, 2026 |
Jan. 01, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Schedule of Warrants [Line Items] | ||||
| Number of Warrants, Outstanding balance | 24,765 | 65 | 24,765 | 65 |
| Weighted Average Exercise price, Outstanding balance | $ 509.05 | $ 119,371 | $ 509.05 | $ 119,371 |
| Average Remaining Contractual Term, Outstanding balance | 4 years 8 months 26 days | 3 years 18 days | 4 years 5 months 26 days | 2 years 9 months 18 days |
| Number of warrants, Exercisable | 24,765 | 28 | ||
| weighted average exercise price, Exercisable | $ 509.05 | $ 119,371 | ||
| Average Remaining Contractual Term, Exercisable | 4 years 5 months 26 days | 2 years 6 months 25 days | ||
| Number of Warrants, Granted | 260,000 | |||
| Weighted Average Exercise price, Granted | $ 5.81 | |||
| Average Remaining Contractual Term, Granted | 1511 years | |||
| Number of Warrants, Exercised | (260,000) | |||
| Weighted Average Exercise price, Exercised | $ 5.81 | |||
| Average Remaining Contractual Term, Exercised | minus 1511 years | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of warrants, exercisable. No definition available.
|
| X | ||||||||||
- Definition Number of warrants, exercised. No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term,exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term,granted/issued. No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value as weighted average exercise price, exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for non-option awards exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|